Ligand Pharmaceuticals Inc Q3 2024 Everything You Need To Know Ahead Of Earnings
| CCASX Fund | USD 83.63 0.27 0.32% |
Slightly above 53% of Conestoga Small's investor base is interested to short. The analysis of overall sentiment of trading Conestoga Small Cap mutual fund suggests that many investors are impartial at this time. Conestoga Small's investing sentiment can be driven by a variety of factors including economic data, Conestoga Small's earnings reports, geopolitical events, and overall market trends.
Conestoga |
Ligand Pharmaceuticals Inc is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is 40.65 million, and the earnings are expected to come in at 0.58 per share. The full year 2024s revenue is expected to be 156.38 million and the earnings are expected to be 3.30 per share.
Read at finance.yahoo.com
 |
Conestoga Small Fundamental Analysis
We analyze Conestoga Small's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Conestoga Small using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Conestoga Small based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Conestoga Small is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Conestoga Small Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Conestoga Small mutual fund to make a market-neutral strategy. Peer analysis of Conestoga Small could also be used in its relative valuation, which is a method of valuing Conestoga Small by comparing valuation metrics with similar companies.
Peers
Conestoga Small Related Equities
| FSELX | Fidelity Select | 1.69 | ||||
| CMIRX | Conestoga Micro | 0.72 | ||||
| VFIAX | Vanguard 500 | 0.57 | ||||
| AMEIX | Equity Growth | 0.55 | ||||
| FBALX | Fidelity Balanced | 0.49 | ||||
| BALFX | American Balanced | 0.46 | ||||
| CCSMX | Conestoga Smid | 0.29 | ||||
| CCMAX | Columbia Large | 0.1 | ||||
| RNGHX | New Economy | 0.48 |
Other Information on Investing in Conestoga Mutual Fund
Conestoga Small financial ratios help investors to determine whether Conestoga Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Conestoga with respect to the benefits of owning Conestoga Small security.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |